Shionogi & Co Ltd 2017 Integrated Report
The report records Shionogi's record net sales, operating income and ordinary income in fiscal 2016 after overcoming the Crestor patent cliff. It links the company's pharmaceutical mission and HIV-related R&D to SDG 3 and describes the Mother to Mother SHIONOGI Project, including a clinic opened in Kenya. The report also presents an established Environment, Health, and Safety management system addressing climate change, water resources, suppliers and workplace safety.
Company: Shionogi & Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2017
Type: Integrated Report
Pages: 77
Back to company
Shionogi & Co Ltd
Integrated Report
The report records Shionogi's record net sales, operating income and ordinary income in fiscal 2016 after overcoming the Crestor patent cliff. It links the company's pharmaceutical mission and HIV-related R&D to SDG 3 and describes the Mother to Mother SHIONOGI Project, including a clinic opened in Kenya. The report also presents an established Environment, Health, and Safety management system addressing climate change, water resources, suppliers and workplace safety.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Apr 1, 2016 - Mar 31, 2017
Fiscal Year
2016
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Total Waste
Employees